Horsetalk.co.nz - Full Article
July 25, 2017
Horsetalk.co.nz
A rider in Saudi Arabia has been suspended for a year and fined 2500 Swiss francs after his mount in a 110km endurance ride last January tested positive for phenylbutazone, oxyphenbutazone, and dexamethasone.
Ibrahim Abdulrahman Alsughayer rode the horse Nashmi Alghzlan in a CEI1* 110km race in Riyadh, Saudi Arabia, on January 14.
The horse was selected for testing, which revealed the presence of the three substances in the blood. Phenylbutazone and dyphenbutazone – a metabolic byproduct of phenylbutazone – are non-steroidal anti-inflammatory drugs with anti-inflammatory and painkilling effects. Dexamethasone is a corticosteroid drug with anti-inflammatory properties...
Read more at http://www.horsetalk.co.nz/2017/07/25/suspension-fine-endurance-horse-drug/#uO7Pb2PBHLwi5Lpd.99
Faster, Higher, Further: How Julie Curchod is Excelling in Jumping and Endurance
FEI.org - Full Story 05 May 2025 Words by Stacey Stearns Photos courtesy of Julie and Véronique Curchod The promising Swiss athlete is ...
-
Inside.fei.org 17 December 2020 The FEI Board took a series of key decisions on allocation, cancellation, and reopening of bids for FEI C...
-
Inside.FEI.org 02 September 2024 Author: Mirjam van Huet A total of 145 athletes and 155 horses are currently preparing for the journe...
-
- World’s most prestigious equestrian endurance event takes place 7-9 February 2025 - Custodian of the Two Holy Mosques Endurance Cup off...
